OREANDA-NEWS. The American company Pfizer and the German company BioNTech have received temporary permission from the Medicines and Healthcare Products Regulatory Agency of the United Kingdom to use their coronavirus vaccine in the country/ This was reported on the website of BioNTech. The company noted that this is the first approval for the use of the medication.

The developers are ready to deliver the first doses of the vaccine to Great Britain immediately, the report adds. The companies previously signed an agreement to supply up to 40 million doses of vaccine to the United Kingdom in 2020 and 2021. The enterprises previously reported that their vaccine is 95 % effective.

In December, Pfizer and BioNTech will await decisions on similar applications from the regulators of the United states of America and European Union.